WeVote
Log In

Bill

Bill

A 1722

Relates to reducing pharmacy benefit manager costs

2025 Regular Session Introduced by David Weprin

New York A 1722 aims to cut pharmacy benefit manager costs, boosting relief for insurers, employers, pharmacies, and patients; bill currently referred to Insurance.

REFERRED TO INSURANCE
0
WeVote Research Nonpartisan
Bill Summary · A 1722

Summary of New York Assembly Bill A 1722 (Relates to reducing pharmacy benefit manager costs)

Overview

  • Bill number: A 1722
  • Title: Relates to reducing pharmacy benefit manager costs
  • Sponsor: David Weprin (primary)
  • Status: REFERRED TO INSURANCE
  • Introduction date: January 14, 2025
  • Legislative actions to date: Both entries for January 14, 2025 show the bill being REFERRED TO INSURANCE (indicating referral to the Assembly Committee on Insurance)
  • Related bills: A 8165, A 291, A 6352 (prior sessions); S 6161 (companion in the Senate)

Purpose and intent

  • The bill’s stated objective, by its title, is to reduce costs associated with pharmacy benefit managers (PBMs). No specific policy text is provided in the information available here, so the exact mechanisms or requirements proposed by A 1722 are not listed.

Key provisions (current available information)

  • Specific provisions are not included in the provided materials. If enacted, typical elements in PBM reform measures often address issues such as cost transparency, rebates, passthrough pricing, and anti-competitive practices; however, it is not possible to confirm which, if any, of these would be included in A 1722 without the bill text.
  • As introduced, the bill’s primary aim is economic relief related to PBMs, but the exact regulatory tools, thresholds, timelines, penalties, or exemptions are not specified here.

Who would be affected

  • Pharmacy benefit managers (PBMs) operating in New York
  • Health insurers, plan sponsors, and employers that utilize PBMs
  • Pharmacies (independent and chain) and their patients
  • State insurance regulators and agencies responsible for PBM oversight

Procedural/timeline aspects

  • Introduced: January 14, 2025
  • Status: Referred to the Assembly Committee on Insurance (two entries indicate the same referral)
  • Next steps (typical): If advanced, the bill would proceed through committee consideration (hearings, amendments), potentially move to a floor vote in the Assembly, and then progress through the Senate if similar action occurs there (with companion S 6161). The exact calendar and voting timeline depend on committee action and legislative priorities.

Related and companion measures

  • Related (prior sessions): A 8165, A 291, A 6352
  • Senate companion: S 6161 (listed as a companion bill)

Note on available detail

  • The summary reflects the information provided. The full text of A 1722 would be needed to detail the specific provisions, thresholds, dates by which changes would take effect, funding implications, enforcement mechanisms, and any transitional rules.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.